GlassScriptPhysician profile
Jeffrey M Desimone
NPI 1699726737
$25,447.19
in general payments reported to CMS, 2019-2025
6 companies · $1,910 in 2025
The $1,910 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.93 · 2020: $1,569 · 2021: $13K · 2022: $7,000 · 2023: $557 · 2024: $1,503 · 2025: $1,910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,043 · Food and Beverage: $1,222 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,043.19 |
| Food and Beverage | $1,222.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $204.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $23,531.62 | 2021-2025 | Da Vinci Surgical System |
| Standard Bariatrics, INC. | $1,500.00 | 2020 | |
| Novo Nordisk INC | $218.13 | 2019-2025 | Wegovy |
| Davol INC. | $149.97 | 2023 | Phasix Mesh |
| Acelrx Pharmaceuticals, INC. | $31.69 | 2019 | |
| Redhill Biopharma INC. | $15.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Desimone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.